2-anilinopurin-8-ones as inhibitors of TTK/Mps1 for the treatment of proliferative disorders

Details for Australian Patent Application No. 2008290330 (hide)

Owner AstraZeneca AB

Inventors Jones, Clifford David; Andrews, David Michael; Simpson, Iain; Ward, Richard Andrew

Agent Davies Collison Cave

Pub. Number AU-A-2008290330

PCT Pub. Number WO2009/024824

Priority 60/957,508 23.08.07 US

Filing date 20 August 2008

Wipo publication date 26 February 2009

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/52 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

11 March 2010 PCT application entered the National Phase

  PCT publication WO2009/024824 Priority application(s): WO2009/024824

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008290350-Apparatus for coating pipes

2008290329-Cyclopropyl amide derivatives